Kenneth Pierce spotlights a new model for specialty access: full analysis

Kenneth Pierce, DVM, MS, DACVO, is being highlighted not just for a traditional specialist career, but for building a business around one of veterinary medicine’s persistent friction points: access to specialty support. In the March 16, 2026, Vet Life Reimagined episode, Pierce is described as the founder of Veterinary Vision Center in Shreveport, Louisiana, and the creator of VESPECON, a platform meant to connect general practitioners with specialists on demand. (music.amazon.com)

That framing matters because it places Pierce’s career story inside a larger market reality. On Veterinary Vision Center’s website, Pierce is presented as a nationally lecturing veterinary ophthalmologist, and the hospital says it is an in-network specialty hospital of VESPECON. The site describes VESPECON as an advisory support and concierge referral service intended to improve access to specialty care and timely referral appointments. (veterinaryvisioncenter.com)

VESPECON’s own materials expand on that model. The company says it partners with veterinary practices so they can continue managing cases locally while collaborating with board-certified specialists, and it offers specialty consultations, concierge referral support, tele-cardiology, tele-radiology, and continuing education. Its clinical advisor roster spans ophthalmology, internal medicine, surgery, cardiology, dermatology, oncology, behavior, neurology, exotics, and other disciplines, suggesting Pierce has built more than a single-specialty extension of his own practice. (vespecon.com)

Pierce has been making the same case publicly for at least the past year. In a May 13, 2025, podcast interview, he described seeing firsthand what happens when a specialist is covering a large multi-state region, and framed VESPECON as a response to “specialist deserts” where pet parents and referring veterinarians face long travel distances or delays. That description is directionally consistent with broader industry concern over specialist shortages and referral bottlenecks. An ACVIM stakeholder summit white paper has also documented workforce pressure in specialty medicine, while AAHA has emphasized earlier, more collaborative referral relationships between generalists and specialists. (iheart.com)

Industry messaging around VESPECON leans heavily on workflow and continuity. Company materials say practices can consult specialists in a streamlined process and maintain active collaboration through the life of a case, while referral support is used when transfer is necessary. A 2024 PR Newswire release similarly positioned VESPECON as on-demand expertise aimed at helping practices manage increasing case complexity. No major outside financing or regulatory filing tied to Pierce or VESPECON surfaced in this search, so the public story appears to be one of organic company building rather than a newly announced transaction. (vespecon.com)

Why it matters: For veterinary professionals, this is less about one ophthalmologist’s résumé and more about a business model that tries to widen access to specialist input without immediately moving the patient out of primary care. That could appeal to general practices trying to support pet parents in markets where boarded specialists are scarce, booked out, or geographically distant. It also fits a broader shift toward more flexible referral and co-management pathways, especially for practices that want to preserve continuity, strengthen client trust, and give associates more clinical backup on tougher cases. (vespecon.com)

There are still open questions. Company claims about improved access and outcomes are plausible, but the available public materials reviewed here are largely company-authored or podcast descriptions rather than independent outcomes research. For that reason, the strongest takeaway is strategic, not evidentiary: Pierce is part of a growing group of veterinary entrepreneurs trying to turn specialist scarcity into a service layer that supports general practice rather than replacing it. (vespecon.com)

What to watch: The next signal to watch is whether VESPECON publishes stronger utilization or outcomes data, adds more specialty partners or hospital relationships, or becomes more visible in CE and referral-guideline conversations as practices keep looking for scalable ways to manage specialty demand. (vespecon.com)